Palvella Therapeutics (PVLA) Free Cash Flow (QoQ) (2013 - 2026)
Palvella Therapeutics (PVLA) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | Palvella Therapeutics | 1.87 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.18% |
| Dec 31, 2025 | 37.90% |
| Sep 30, 2025 | -45.43% |
| Jun 30, 2025 | 19.74% |
| Mar 31, 2025 | -25.50% |
| Dec 31, 2024 | -96.68% |
| Sep 30, 2024 | -71.05% |
| Jun 30, 2024 | -45.46% |
| Mar 31, 2024 | -105.39% |
| Dec 31, 2023 | 308.95% |
| Sep 30, 2023 | 27.46% |
| Jun 30, 2023 | -22.22% |
| Mar 31, 2023 | 20.79% |
| Dec 31, 2022 | -78.96% |
| Sep 30, 2022 | 51.93% |
| Jun 30, 2022 | 29.63% |
| Mar 31, 2022 | -104.08% |
| Dec 31, 2021 | 23.92% |
| Sep 30, 2021 | -149.98% |
| Jun 30, 2021 | 343.93% |